From Boston’s Moontoast Buys Spendship, a Nashville Startup With WI Roots:

Mobile advertising—

Modern mobile phone with hundred dollar bills on a screen and with credit card. Mobile payment concept. Isolated on white. Image by Anatoliy Babiy, courtesy of depositphotos.com.

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Whitepaper
Decentralized Clinical Trials: The Call for a New Paradigm
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy

Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

From Boston’s Moontoast Buys Spendship, a Nashville Startup With WI Roots:

Underwriters and Partners

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Decentralized Clinical Trials: The Call for a New Paradigm

What to Include in Your Life Sciences Company Fundraising Pitch Deck

Xconomy on Demand

We offer a number of ways to subscribe for free!